scrisori de acreditare Motel băutură bcl2 marker prognostic role colorect reforma fiabilitate minor
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors | Nature Reviews Drug Discovery
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
Frontiers | Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Cancers | Free Full-Text | Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer | Cell Death & Disease
IJMS | Free Full-Text | Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
Biomolecules | Free Full-Text | Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
Cancers | Free Full-Text | Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
PDF) Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
Noncanonical Cell Fate Regulation by Bcl-2 Proteins: Trends in Cell Biology
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression | Cell Death & Disease
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology